nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP11A1—Dexamethasone—multiple sclerosis	0.166	0.233	CbGbCtD
Terbinafine—CYP19A1—Betamethasone—multiple sclerosis	0.133	0.187	CbGbCtD
Terbinafine—CYP19A1—Dexamethasone—multiple sclerosis	0.0771	0.109	CbGbCtD
Terbinafine—CYP2D6—Fingolimod—multiple sclerosis	0.063	0.0888	CbGbCtD
Terbinafine—CYP3A4—Fingolimod—multiple sclerosis	0.0401	0.0564	CbGbCtD
Terbinafine—CYP2C19—Prednisone—multiple sclerosis	0.0324	0.0456	CbGbCtD
Terbinafine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0258	0.0364	CbGbCtD
Terbinafine—CYP2C8—Dexamethasone—multiple sclerosis	0.0241	0.0339	CbGbCtD
Terbinafine—CYP2C19—Dexamethasone—multiple sclerosis	0.0202	0.0285	CbGbCtD
Terbinafine—CYP3A4—Triamcinolone—multiple sclerosis	0.0196	0.0276	CbGbCtD
Terbinafine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0188	0.0265	CbGbCtD
Terbinafine—CYP2C9—Dexamethasone—multiple sclerosis	0.0168	0.0237	CbGbCtD
Terbinafine—CYP3A4—Betamethasone—multiple sclerosis	0.0168	0.0236	CbGbCtD
Terbinafine—CYP3A4—Prednisolone—multiple sclerosis	0.0166	0.0233	CbGbCtD
Terbinafine—CYP3A4—Prednisone—multiple sclerosis	0.0156	0.022	CbGbCtD
Terbinafine—CYP2D6—Dexamethasone—multiple sclerosis	0.0154	0.0216	CbGbCtD
Terbinafine—CYP3A4—Dexamethasone—multiple sclerosis	0.00977	0.0138	CbGbCtD
Terbinafine—SQLE—retina—multiple sclerosis	0.000417	0.117	CbGeAlD
Terbinafine—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000408	0.00573	CbGpPWpGaD
Terbinafine—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000408	0.00573	CbGpPWpGaD
Terbinafine—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000402	0.00565	CbGpPWpGaD
Terbinafine—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000402	0.00565	CbGpPWpGaD
Terbinafine—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000396	0.00557	CbGpPWpGaD
Terbinafine—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000396	0.00557	CbGpPWpGaD
Terbinafine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.00038	0.00534	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000379	0.00533	CbGpPWpGaD
Terbinafine—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000367	0.00516	CbGpPWpGaD
Terbinafine—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000367	0.00516	CbGpPWpGaD
Terbinafine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000353	0.00496	CbGpPWpGaD
Terbinafine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000353	0.00496	CbGpPWpGaD
Terbinafine—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000348	0.00489	CbGpPWpGaD
Terbinafine—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000348	0.00489	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—SRM—multiple sclerosis	0.00034	0.00478	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000339	0.00476	CbGpPWpGaD
Terbinafine—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	0.000338	0.00475	CbGpPWpGaD
Terbinafine—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	0.000338	0.00475	CbGpPWpGaD
Terbinafine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000338	0.00474	CbGpPWpGaD
Terbinafine—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000338	0.00474	CbGpPWpGaD
Terbinafine—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000335	0.0047	CbGpPWpGaD
Terbinafine—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000335	0.0047	CbGpPWpGaD
Terbinafine—CYP11A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000317	0.00445	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000303	0.00425	CbGpPWpGaD
Terbinafine—SQLE—medulla oblongata—multiple sclerosis	0.000302	0.0842	CbGeAlD
Terbinafine—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000286	0.00402	CbGpPWpGaD
Terbinafine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000286	0.00402	CbGpPWpGaD
Terbinafine—SQLE—midbrain—multiple sclerosis	0.000276	0.077	CbGeAlD
Terbinafine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000272	0.00383	CbGpPWpGaD
Terbinafine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000272	0.00383	CbGpPWpGaD
Terbinafine—SQLE—spinal cord—multiple sclerosis	0.000269	0.0751	CbGeAlD
Terbinafine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000269	0.00378	CbGpPWpGaD
Terbinafine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000269	0.00378	CbGpPWpGaD
Terbinafine—Vertigo—Methylprednisolone—multiple sclerosis	0.000263	0.00122	CcSEcCtD
Terbinafine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000262	0.00122	CcSEcCtD
Terbinafine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000262	0.00122	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000261	0.00121	CcSEcCtD
Terbinafine—Neutropenia—Methotrexate—multiple sclerosis	0.00026	0.00121	CcSEcCtD
Terbinafine—Dizziness—Azathioprine—multiple sclerosis	0.00026	0.00121	CcSEcCtD
Terbinafine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00026	0.00121	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000259	0.0012	CcSEcCtD
Terbinafine—CYP11A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000257	0.00361	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—TLR4—multiple sclerosis	0.000257	0.00361	CbGpPWpGaD
Terbinafine—Cough—Triamcinolone—multiple sclerosis	0.000256	0.00119	CcSEcCtD
Terbinafine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000254	0.00118	CcSEcCtD
Terbinafine—Urticaria—Mitoxantrone—multiple sclerosis	0.000253	0.00117	CcSEcCtD
Terbinafine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000251	0.00117	CcSEcCtD
Terbinafine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000251	0.00117	CcSEcCtD
Terbinafine—Myalgia—Triamcinolone—multiple sclerosis	0.00025	0.00116	CcSEcCtD
Terbinafine—Vomiting—Azathioprine—multiple sclerosis	0.00025	0.00116	CcSEcCtD
Terbinafine—Arthralgia—Methylprednisolone—multiple sclerosis	0.00025	0.00116	CcSEcCtD
Terbinafine—Myalgia—Methylprednisolone—multiple sclerosis	0.00025	0.00116	CcSEcCtD
Terbinafine—Eye disorder—Prednisone—multiple sclerosis	0.000249	0.00116	CcSEcCtD
Terbinafine—Anxiety—Methylprednisolone—multiple sclerosis	0.000249	0.00116	CcSEcCtD
Terbinafine—Infestation NOS—Methotrexate—multiple sclerosis	0.000248	0.00115	CcSEcCtD
Terbinafine—Infestation—Methotrexate—multiple sclerosis	0.000248	0.00115	CcSEcCtD
Terbinafine—Rash—Azathioprine—multiple sclerosis	0.000248	0.00115	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000248	0.00115	CcSEcCtD
Terbinafine—Dermatitis—Azathioprine—multiple sclerosis	0.000248	0.00115	CcSEcCtD
Terbinafine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000247	0.00115	CcSEcCtD
Terbinafine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000247	0.00115	CcSEcCtD
Terbinafine—Discomfort—Triamcinolone—multiple sclerosis	0.000247	0.00115	CcSEcCtD
Terbinafine—Discomfort—Methylprednisolone—multiple sclerosis	0.000247	0.00115	CcSEcCtD
Terbinafine—Headache—Azathioprine—multiple sclerosis	0.000246	0.00114	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000246	0.00114	CcSEcCtD
Terbinafine—Dry mouth—Triamcinolone—multiple sclerosis	0.000245	0.00114	CcSEcCtD
Terbinafine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000244	0.00343	CbGpPWpGaD
Terbinafine—Angioedema—Betamethasone—multiple sclerosis	0.000244	0.00113	CcSEcCtD
Terbinafine—Angioedema—Dexamethasone—multiple sclerosis	0.000244	0.00113	CcSEcCtD
Terbinafine—Angiopathy—Prednisone—multiple sclerosis	0.000242	0.00112	CcSEcCtD
Terbinafine—Confusional state—Methylprednisolone—multiple sclerosis	0.000241	0.00112	CcSEcCtD
Terbinafine—Immune system disorder—Prednisone—multiple sclerosis	0.000241	0.00112	CcSEcCtD
Terbinafine—Malaise—Dexamethasone—multiple sclerosis	0.00024	0.00112	CcSEcCtD
Terbinafine—Malaise—Betamethasone—multiple sclerosis	0.00024	0.00112	CcSEcCtD
Terbinafine—SQLE—Metabolism—CYP27B1—multiple sclerosis	0.00024	0.00337	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—CYP24A1—multiple sclerosis	0.00024	0.00337	CbGpPWpGaD
Terbinafine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00024	0.00111	CcSEcCtD
Terbinafine—Vertigo—Dexamethasone—multiple sclerosis	0.00024	0.00111	CcSEcCtD
Terbinafine—Vertigo—Betamethasone—multiple sclerosis	0.00024	0.00111	CcSEcCtD
Terbinafine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000239	0.00111	CcSEcCtD
Terbinafine—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000239	0.00335	CbGpPWpGaD
Terbinafine—Infection—Triamcinolone—multiple sclerosis	0.000238	0.00111	CcSEcCtD
Terbinafine—Infection—Methylprednisolone—multiple sclerosis	0.000238	0.0011	CcSEcCtD
Terbinafine—Alopecia—Prednisone—multiple sclerosis	0.000236	0.0011	CcSEcCtD
Terbinafine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000235	0.00109	CcSEcCtD
Terbinafine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000235	0.00109	CcSEcCtD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000234	0.00329	CbGpPWpGaD
Terbinafine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000234	0.00109	CcSEcCtD
Terbinafine—Paraesthesia—Prednisolone—multiple sclerosis	0.000234	0.00109	CcSEcCtD
Terbinafine—Mental disorder—Prednisone—multiple sclerosis	0.000234	0.00109	CcSEcCtD
Terbinafine—Nausea—Azathioprine—multiple sclerosis	0.000234	0.00109	CcSEcCtD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000233	0.00327	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000233	0.00327	CbGpPWpGaD
Terbinafine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000232	0.00108	CcSEcCtD
Terbinafine—Erythema—Prednisone—multiple sclerosis	0.000232	0.00108	CcSEcCtD
Terbinafine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000232	0.00108	CcSEcCtD
Terbinafine—Asthenia—Mitoxantrone—multiple sclerosis	0.000228	0.00106	CcSEcCtD
Terbinafine—Myalgia—Betamethasone—multiple sclerosis	0.000227	0.00105	CcSEcCtD
Terbinafine—Myalgia—Dexamethasone—multiple sclerosis	0.000227	0.00105	CcSEcCtD
Terbinafine—SQLE—nervous system—multiple sclerosis	0.000227	0.0633	CbGeAlD
Terbinafine—Anxiety—Betamethasone—multiple sclerosis	0.000226	0.00105	CcSEcCtD
Terbinafine—Anxiety—Dexamethasone—multiple sclerosis	0.000226	0.00105	CcSEcCtD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.000225	0.00316	CbGpPWpGaD
Terbinafine—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	0.000225	0.00316	CbGpPWpGaD
Terbinafine—Discomfort—Dexamethasone—multiple sclerosis	0.000224	0.00104	CcSEcCtD
Terbinafine—Discomfort—Betamethasone—multiple sclerosis	0.000224	0.00104	CcSEcCtD
Terbinafine—Pain—Prednisolone—multiple sclerosis	0.000223	0.00104	CcSEcCtD
Terbinafine—Hepatitis—Methotrexate—multiple sclerosis	0.000223	0.00104	CcSEcCtD
Terbinafine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000221	0.0031	CbGpPWpGaD
Terbinafine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000221	0.0031	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—GPC5—multiple sclerosis	0.000219	0.00308	CbGpPWpGaD
Terbinafine—Vision blurred—Prednisone—multiple sclerosis	0.000219	0.00102	CcSEcCtD
Terbinafine—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000219	0.00307	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000219	0.00307	CbGpPWpGaD
Terbinafine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000219	0.00102	CcSEcCtD
Terbinafine—SQLE—central nervous system—multiple sclerosis	0.000218	0.0609	CbGeAlD
Terbinafine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000218	0.00101	CcSEcCtD
Terbinafine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000218	0.00101	CcSEcCtD
Terbinafine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000218	0.00101	CcSEcCtD
Terbinafine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000218	0.00101	CcSEcCtD
Terbinafine—Infection—Betamethasone—multiple sclerosis	0.000216	0.001	CcSEcCtD
Terbinafine—Infection—Dexamethasone—multiple sclerosis	0.000216	0.001	CcSEcCtD
Terbinafine—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000216	0.00303	CbGpPWpGaD
Terbinafine—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000216	0.00303	CbGpPWpGaD
Terbinafine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000215	0.001	CcSEcCtD
Terbinafine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000215	0.001	CcSEcCtD
Terbinafine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000215	0.000999	CcSEcCtD
Terbinafine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000215	0.000998	CcSEcCtD
Terbinafine—Visual impairment—Methotrexate—multiple sclerosis	0.000215	0.000998	CcSEcCtD
Terbinafine—Anaemia—Prednisone—multiple sclerosis	0.000215	0.000997	CcSEcCtD
Terbinafine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000213	0.000992	CcSEcCtD
Terbinafine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000213	0.000992	CcSEcCtD
Terbinafine—SQLE—cerebellum—multiple sclerosis	0.000213	0.0596	CbGeAlD
Terbinafine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000213	0.00099	CcSEcCtD
Terbinafine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000213	0.00099	CcSEcCtD
Terbinafine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000213	0.00299	CbGpPWpGaD
Terbinafine—Angioedema—Prednisone—multiple sclerosis	0.000212	0.000986	CcSEcCtD
Terbinafine—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000212	0.00298	CbGpPWpGaD
Terbinafine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000211	0.000981	CcSEcCtD
Terbinafine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000211	0.000979	CcSEcCtD
Terbinafine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000211	0.000979	CcSEcCtD
Terbinafine—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00021	0.00295	CbGpPWpGaD
Terbinafine—Malaise—Prednisone—multiple sclerosis	0.000209	0.000973	CcSEcCtD
Terbinafine—Vertigo—Prednisone—multiple sclerosis	0.000209	0.000969	CcSEcCtD
Terbinafine—Eye disorder—Methotrexate—multiple sclerosis	0.000208	0.000968	CcSEcCtD
Terbinafine—Tinnitus—Methotrexate—multiple sclerosis	0.000208	0.000966	CcSEcCtD
Terbinafine—Anorexia—Betamethasone—multiple sclerosis	0.000207	0.000964	CcSEcCtD
Terbinafine—Anorexia—Dexamethasone—multiple sclerosis	0.000207	0.000964	CcSEcCtD
Terbinafine—Urticaria—Prednisolone—multiple sclerosis	0.000207	0.000963	CcSEcCtD
Terbinafine—Fatigue—Triamcinolone—multiple sclerosis	0.000207	0.000961	CcSEcCtD
Terbinafine—Fatigue—Methylprednisolone—multiple sclerosis	0.000206	0.000959	CcSEcCtD
Terbinafine—Pain—Triamcinolone—multiple sclerosis	0.000205	0.000953	CcSEcCtD
Terbinafine—Angiopathy—Methotrexate—multiple sclerosis	0.000202	0.00094	CcSEcCtD
Terbinafine—Vomiting—Mitoxantrone—multiple sclerosis	0.000202	0.000939	CcSEcCtD
Terbinafine—Immune system disorder—Methotrexate—multiple sclerosis	0.000201	0.000936	CcSEcCtD
Terbinafine—Rash—Mitoxantrone—multiple sclerosis	0.0002	0.000931	CcSEcCtD
Terbinafine—Dermatitis—Mitoxantrone—multiple sclerosis	0.0002	0.00093	CcSEcCtD
Terbinafine—Headache—Mitoxantrone—multiple sclerosis	0.000199	0.000925	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000198	0.000921	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000198	0.000921	CcSEcCtD
Terbinafine—Arthralgia—Prednisone—multiple sclerosis	0.000198	0.000919	CcSEcCtD
Terbinafine—Myalgia—Prednisone—multiple sclerosis	0.000198	0.000919	CcSEcCtD
Terbinafine—CYP11A1—medulla oblongata—multiple sclerosis	0.000198	0.0552	CbGeAlD
Terbinafine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000198	0.000918	CcSEcCtD
Terbinafine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000197	0.000916	CcSEcCtD
Terbinafine—Anxiety—Prednisone—multiple sclerosis	0.000197	0.000915	CcSEcCtD
Terbinafine—Alopecia—Methotrexate—multiple sclerosis	0.000197	0.000915	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000196	0.000912	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000196	0.000909	CcSEcCtD
Terbinafine—Paraesthesia—Betamethasone—multiple sclerosis	0.000195	0.000908	CcSEcCtD
Terbinafine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000195	0.000908	CcSEcCtD
Terbinafine—Discomfort—Prednisone—multiple sclerosis	0.000195	0.000908	CcSEcCtD
Terbinafine—Mental disorder—Methotrexate—multiple sclerosis	0.000195	0.000907	CcSEcCtD
Terbinafine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000195	0.00274	CbGpPWpGaD
Terbinafine—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000195	0.00274	CbGpPWpGaD
Terbinafine—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000195	0.00274	CbGpPWpGaD
Terbinafine—Erythema—Methotrexate—multiple sclerosis	0.000194	0.000902	CcSEcCtD
Terbinafine—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000193	0.00271	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000192	0.0027	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000192	0.0027	CbGpPWpGaD
Terbinafine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000192	0.000893	CcSEcCtD
Terbinafine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000192	0.00089	CcSEcCtD
Terbinafine—Dyspepsia—Betamethasone—multiple sclerosis	0.000192	0.00089	CcSEcCtD
Terbinafine—Urticaria—Triamcinolone—multiple sclerosis	0.000191	0.000885	CcSEcCtD
Terbinafine—Urticaria—Methylprednisolone—multiple sclerosis	0.00019	0.000883	CcSEcCtD
Terbinafine—Dysgeusia—Methotrexate—multiple sclerosis	0.00019	0.000883	CcSEcCtD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.00019	0.00267	CbGpPWpGaD
Terbinafine—Body temperature increased—Triamcinolone—multiple sclerosis	0.00019	0.000881	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisone—multiple sclerosis	0.00019	0.000881	CcSEcCtD
Terbinafine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000189	0.000879	CcSEcCtD
Terbinafine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000189	0.000879	CcSEcCtD
Terbinafine—Decreased appetite—Betamethasone—multiple sclerosis	0.000189	0.000879	CcSEcCtD
Terbinafine—Nausea—Mitoxantrone—multiple sclerosis	0.000189	0.000877	CcSEcCtD
Terbinafine—Infection—Prednisone—multiple sclerosis	0.000188	0.000875	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000188	0.000873	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000188	0.000873	CcSEcCtD
Terbinafine—Fatigue—Betamethasone—multiple sclerosis	0.000188	0.000872	CcSEcCtD
Terbinafine—Fatigue—Dexamethasone—multiple sclerosis	0.000188	0.000872	CcSEcCtD
Terbinafine—Pain—Dexamethasone—multiple sclerosis	0.000186	0.000865	CcSEcCtD
Terbinafine—Pain—Betamethasone—multiple sclerosis	0.000186	0.000865	CcSEcCtD
Terbinafine—Nervous system disorder—Prednisone—multiple sclerosis	0.000186	0.000864	CcSEcCtD
Terbinafine—Skin disorder—Prednisone—multiple sclerosis	0.000184	0.000855	CcSEcCtD
Terbinafine—Vision blurred—Methotrexate—multiple sclerosis	0.000183	0.00085	CcSEcCtD
Terbinafine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000182	0.00255	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—RRM1—multiple sclerosis	0.000182	0.00255	CbGpPWpGaD
Terbinafine—Anorexia—Prednisone—multiple sclerosis	0.000181	0.000839	CcSEcCtD
Terbinafine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00018	0.000837	CcSEcCtD
Terbinafine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000179	0.00252	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000179	0.00252	CbGpPWpGaD
Terbinafine—Anaemia—Methotrexate—multiple sclerosis	0.000179	0.000833	CcSEcCtD
Terbinafine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000179	0.000833	CcSEcCtD
Terbinafine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000179	0.000833	CcSEcCtD
Terbinafine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000178	0.000827	CcSEcCtD
Terbinafine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000178	0.000827	CcSEcCtD
Terbinafine—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000178	0.0025	CbGpPWpGaD
Terbinafine—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000178	0.0025	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000177	0.00249	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000177	0.00249	CbGpPWpGaD
Terbinafine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000177	0.000821	CcSEcCtD
Terbinafine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000176	0.000819	CcSEcCtD
Terbinafine—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000175	0.00246	CbGpPWpGaD
Terbinafine—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000175	0.00246	CbGpPWpGaD
Terbinafine—Malaise—Methotrexate—multiple sclerosis	0.000175	0.000813	CcSEcCtD
Terbinafine—Vertigo—Methotrexate—multiple sclerosis	0.000174	0.00081	CcSEcCtD
Terbinafine—SQLE—brain—multiple sclerosis	0.000173	0.0484	CbGeAlD
Terbinafine—Urticaria—Dexamethasone—multiple sclerosis	0.000173	0.000803	CcSEcCtD
Terbinafine—Urticaria—Betamethasone—multiple sclerosis	0.000173	0.000803	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000173	0.000802	CcSEcCtD
Terbinafine—Dizziness—Prednisolone—multiple sclerosis	0.000172	0.000801	CcSEcCtD
Terbinafine—Asthenia—Triamcinolone—multiple sclerosis	0.000172	0.0008	CcSEcCtD
Terbinafine—Abdominal pain—Betamethasone—multiple sclerosis	0.000172	0.000799	CcSEcCtD
Terbinafine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000172	0.000799	CcSEcCtD
Terbinafine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000172	0.000799	CcSEcCtD
Terbinafine—Body temperature increased—Betamethasone—multiple sclerosis	0.000172	0.000799	CcSEcCtD
Terbinafine—Asthenia—Methylprednisolone—multiple sclerosis	0.000172	0.000798	CcSEcCtD
Terbinafine—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00017	0.00239	CbGpPWpGaD
Terbinafine—Paraesthesia—Prednisone—multiple sclerosis	0.00017	0.000791	CcSEcCtD
Terbinafine—Pruritus—Triamcinolone—multiple sclerosis	0.00017	0.000788	CcSEcCtD
Terbinafine—Cough—Methotrexate—multiple sclerosis	0.000169	0.000787	CcSEcCtD
Terbinafine—Pruritus—Methylprednisolone—multiple sclerosis	0.000169	0.000787	CcSEcCtD
Terbinafine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000168	0.00236	CbGpPWpGaD
Terbinafine—Dyspepsia—Prednisone—multiple sclerosis	0.000167	0.000775	CcSEcCtD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.000166	0.00234	CbGpPWpGaD
Terbinafine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000165	0.00232	CbGpPWpGaD
Terbinafine—Myalgia—Methotrexate—multiple sclerosis	0.000165	0.000768	CcSEcCtD
Terbinafine—Chest pain—Methotrexate—multiple sclerosis	0.000165	0.000768	CcSEcCtD
Terbinafine—Arthralgia—Methotrexate—multiple sclerosis	0.000165	0.000768	CcSEcCtD
Terbinafine—Decreased appetite—Prednisone—multiple sclerosis	0.000165	0.000765	CcSEcCtD
Terbinafine—Rash—Prednisolone—multiple sclerosis	0.000164	0.000764	CcSEcCtD
Terbinafine—Dermatitis—Prednisolone—multiple sclerosis	0.000164	0.000763	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000164	0.000762	CcSEcCtD
Terbinafine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000164	0.000761	CcSEcCtD
Terbinafine—Fatigue—Prednisone—multiple sclerosis	0.000163	0.000759	CcSEcCtD
Terbinafine—Headache—Prednisolone—multiple sclerosis	0.000163	0.000759	CcSEcCtD
Terbinafine—Discomfort—Methotrexate—multiple sclerosis	0.000163	0.000758	CcSEcCtD
Terbinafine—Confusional state—Methotrexate—multiple sclerosis	0.00016	0.000742	CcSEcCtD
Terbinafine—Dizziness—Triamcinolone—multiple sclerosis	0.000159	0.000737	CcSEcCtD
Terbinafine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000158	0.000736	CcSEcCtD
Terbinafine—Dizziness—Methylprednisolone—multiple sclerosis	0.000158	0.000735	CcSEcCtD
Terbinafine—Infection—Methotrexate—multiple sclerosis	0.000157	0.000731	CcSEcCtD
Terbinafine—Feeling abnormal—Prednisone—multiple sclerosis	0.000156	0.000726	CcSEcCtD
Terbinafine—Asthenia—Dexamethasone—multiple sclerosis	0.000156	0.000725	CcSEcCtD
Terbinafine—Asthenia—Betamethasone—multiple sclerosis	0.000156	0.000725	CcSEcCtD
Terbinafine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000155	0.000722	CcSEcCtD
Terbinafine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000155	0.000721	CcSEcCtD
Terbinafine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000155	0.00072	CcSEcCtD
Terbinafine—Nausea—Prednisolone—multiple sclerosis	0.000155	0.00072	CcSEcCtD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000154	0.00217	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000154	0.00217	CbGpPWpGaD
Terbinafine—Pruritus—Dexamethasone—multiple sclerosis	0.000154	0.000715	CcSEcCtD
Terbinafine—Pruritus—Betamethasone—multiple sclerosis	0.000154	0.000715	CcSEcCtD
Terbinafine—Skin disorder—Methotrexate—multiple sclerosis	0.000154	0.000715	CcSEcCtD
Terbinafine—Vomiting—Triamcinolone—multiple sclerosis	0.000152	0.000709	CcSEcCtD
Terbinafine—Vomiting—Methylprednisolone—multiple sclerosis	0.000152	0.000707	CcSEcCtD
Terbinafine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000152	0.00213	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000152	0.00213	CbGpPWpGaD
Terbinafine—Rash—Triamcinolone—multiple sclerosis	0.000151	0.000703	CcSEcCtD
Terbinafine—Dermatitis—Triamcinolone—multiple sclerosis	0.000151	0.000702	CcSEcCtD
Terbinafine—Anorexia—Methotrexate—multiple sclerosis	0.000151	0.000701	CcSEcCtD
Terbinafine—Rash—Methylprednisolone—multiple sclerosis	0.000151	0.000701	CcSEcCtD
Terbinafine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000151	0.0007	CcSEcCtD
Terbinafine—Urticaria—Prednisone—multiple sclerosis	0.000151	0.0007	CcSEcCtD
Terbinafine—Headache—Triamcinolone—multiple sclerosis	0.00015	0.000698	CcSEcCtD
Terbinafine—Headache—Methylprednisolone—multiple sclerosis	0.00015	0.000697	CcSEcCtD
Terbinafine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00015	0.00211	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00015	0.00211	CbGpPWpGaD
Terbinafine—Abdominal pain—Prednisone—multiple sclerosis	0.00015	0.000696	CcSEcCtD
Terbinafine—Body temperature increased—Prednisone—multiple sclerosis	0.00015	0.000696	CcSEcCtD
Terbinafine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000149	0.000692	CcSEcCtD
Terbinafine—Diarrhoea—Betamethasone—multiple sclerosis	0.000149	0.000692	CcSEcCtD
Terbinafine—CYP11A1—nervous system—multiple sclerosis	0.000149	0.0415	CbGeAlD
Terbinafine—CYP11A1—Metabolism—SRM—multiple sclerosis	0.000147	0.00207	CbGpPWpGaD
Terbinafine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000144	0.00067	CcSEcCtD
Terbinafine—Dizziness—Betamethasone—multiple sclerosis	0.000144	0.000669	CcSEcCtD
Terbinafine—Dizziness—Dexamethasone—multiple sclerosis	0.000144	0.000669	CcSEcCtD
Terbinafine—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000143	0.00201	CbGpPWpGaD
Terbinafine—CYP11A1—central nervous system—multiple sclerosis	0.000143	0.0399	CbGeAlD
Terbinafine—Nausea—Triamcinolone—multiple sclerosis	0.000142	0.000662	CcSEcCtD
Terbinafine—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000142	0.002	CbGpPWpGaD
Terbinafine—Paraesthesia—Methotrexate—multiple sclerosis	0.000142	0.000661	CcSEcCtD
Terbinafine—Nausea—Methylprednisolone—multiple sclerosis	0.000142	0.00066	CcSEcCtD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000141	0.00198	CbGpPWpGaD
Terbinafine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00014	0.00197	CbGpPWpGaD
Terbinafine—Hypersensitivity—Prednisone—multiple sclerosis	0.00014	0.000649	CcSEcCtD
Terbinafine—Dyspepsia—Methotrexate—multiple sclerosis	0.000139	0.000648	CcSEcCtD
Terbinafine—Vomiting—Betamethasone—multiple sclerosis	0.000138	0.000643	CcSEcCtD
Terbinafine—Vomiting—Dexamethasone—multiple sclerosis	0.000138	0.000643	CcSEcCtD
Terbinafine—Decreased appetite—Methotrexate—multiple sclerosis	0.000138	0.00064	CcSEcCtD
Terbinafine—Rash—Betamethasone—multiple sclerosis	0.000137	0.000638	CcSEcCtD
Terbinafine—Rash—Dexamethasone—multiple sclerosis	0.000137	0.000638	CcSEcCtD
Terbinafine—Dermatitis—Betamethasone—multiple sclerosis	0.000137	0.000637	CcSEcCtD
Terbinafine—Dermatitis—Dexamethasone—multiple sclerosis	0.000137	0.000637	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000137	0.000635	CcSEcCtD
Terbinafine—Fatigue—Methotrexate—multiple sclerosis	0.000137	0.000634	CcSEcCtD
Terbinafine—CYP11A1—Biological oxidations—POMC—multiple sclerosis	0.000136	0.00192	CbGpPWpGaD
Terbinafine—Headache—Dexamethasone—multiple sclerosis	0.000136	0.000633	CcSEcCtD
Terbinafine—Headache—Betamethasone—multiple sclerosis	0.000136	0.000633	CcSEcCtD
Terbinafine—Asthenia—Prednisone—multiple sclerosis	0.000136	0.000632	CcSEcCtD
Terbinafine—Pain—Methotrexate—multiple sclerosis	0.000135	0.000629	CcSEcCtD
Terbinafine—Pruritus—Prednisone—multiple sclerosis	0.000134	0.000623	CcSEcCtD
Terbinafine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000131	0.000606	CcSEcCtD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00013	0.00182	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00013	0.00182	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.00013	0.00182	CbGpPWpGaD
Terbinafine—Diarrhoea—Prednisone—multiple sclerosis	0.00013	0.000602	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00013	0.000602	CcSEcCtD
Terbinafine—Nausea—Betamethasone—multiple sclerosis	0.000129	0.000601	CcSEcCtD
Terbinafine—Nausea—Dexamethasone—multiple sclerosis	0.000129	0.000601	CcSEcCtD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.000127	0.00179	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000127	0.00179	CbGpPWpGaD
Terbinafine—Urticaria—Methotrexate—multiple sclerosis	0.000126	0.000585	CcSEcCtD
Terbinafine—Dizziness—Prednisone—multiple sclerosis	0.000125	0.000582	CcSEcCtD
Terbinafine—Body temperature increased—Methotrexate—multiple sclerosis	0.000125	0.000582	CcSEcCtD
Terbinafine—Abdominal pain—Methotrexate—multiple sclerosis	0.000125	0.000582	CcSEcCtD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000121	0.0017	CbGpPWpGaD
Terbinafine—Vomiting—Prednisone—multiple sclerosis	0.00012	0.00056	CcSEcCtD
Terbinafine—Rash—Prednisone—multiple sclerosis	0.000119	0.000555	CcSEcCtD
Terbinafine—Dermatitis—Prednisone—multiple sclerosis	0.000119	0.000555	CcSEcCtD
Terbinafine—Headache—Prednisone—multiple sclerosis	0.000119	0.000552	CcSEcCtD
Terbinafine—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000119	0.00167	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000117	0.00165	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000117	0.00165	CbGpPWpGaD
Terbinafine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000117	0.000542	CcSEcCtD
Terbinafine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000116	0.00163	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000116	0.00163	CbGpPWpGaD
Terbinafine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000114	0.0016	CbGpPWpGaD
Terbinafine—Asthenia—Methotrexate—multiple sclerosis	0.000114	0.000528	CcSEcCtD
Terbinafine—CYP11A1—brain—multiple sclerosis	0.000114	0.0317	CbGeAlD
Terbinafine—Nausea—Prednisone—multiple sclerosis	0.000113	0.000523	CcSEcCtD
Terbinafine—Pruritus—Methotrexate—multiple sclerosis	0.000112	0.000521	CcSEcCtD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.00011	0.00155	CbGpPWpGaD
Terbinafine—Diarrhoea—Methotrexate—multiple sclerosis	0.000108	0.000504	CcSEcCtD
Terbinafine—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000108	0.00152	CbGpPWpGaD
Terbinafine—Dizziness—Methotrexate—multiple sclerosis	0.000105	0.000487	CcSEcCtD
Terbinafine—SQLE—Metabolism—BCHE—multiple sclerosis	0.000104	0.00147	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CYP27B1—multiple sclerosis	0.000104	0.00146	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CYP24A1—multiple sclerosis	0.000104	0.00146	CbGpPWpGaD
Terbinafine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000102	0.00143	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000101	0.00142	CbGpPWpGaD
Terbinafine—Vomiting—Methotrexate—multiple sclerosis	0.000101	0.000468	CcSEcCtD
Terbinafine—Rash—Methotrexate—multiple sclerosis	9.99e-05	0.000464	CcSEcCtD
Terbinafine—Dermatitis—Methotrexate—multiple sclerosis	9.98e-05	0.000464	CcSEcCtD
Terbinafine—Headache—Methotrexate—multiple sclerosis	9.92e-05	0.000461	CcSEcCtD
Terbinafine—CYP19A1—Metabolism—SRM—multiple sclerosis	9.76e-05	0.00137	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	9.65e-05	0.00136	CbGpPWpGaD
Terbinafine—CYP19A1—nervous system—multiple sclerosis	9.65e-05	0.027	CbGeAlD
Terbinafine—CYP11A1—Metabolism—GPC5—multiple sclerosis	9.49e-05	0.00133	CbGpPWpGaD
Terbinafine—Nausea—Methotrexate—multiple sclerosis	9.41e-05	0.000437	CcSEcCtD
Terbinafine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.37e-05	0.00132	CbGpPWpGaD
Terbinafine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.29e-05	0.00131	CbGpPWpGaD
Terbinafine—CYP19A1—central nervous system—multiple sclerosis	9.29e-05	0.0259	CbGeAlD
Terbinafine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.25e-05	0.0013	CbGpPWpGaD
Terbinafine—CYP19A1—Biological oxidations—POMC—multiple sclerosis	9.04e-05	0.00127	CbGpPWpGaD
Terbinafine—CYP2D6—brainstem—multiple sclerosis	8.79e-05	0.0245	CbGeAlD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.39e-05	0.00118	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.39e-05	0.00118	CbGpPWpGaD
Terbinafine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.26e-05	0.00116	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—SRM—multiple sclerosis	8.21e-05	0.00115	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	8.17e-05	0.00115	CbGpPWpGaD
Terbinafine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.94e-05	0.00112	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—RRM1—multiple sclerosis	7.86e-05	0.0011	CbGpPWpGaD
Terbinafine—PTGS1—Biological oxidations—POMC—multiple sclerosis	7.61e-05	0.00107	CbGpPWpGaD
Terbinafine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.6e-05	0.00107	CbGpPWpGaD
Terbinafine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.53e-05	0.00106	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.49e-05	0.00105	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.49e-05	0.00105	CbGpPWpGaD
Terbinafine—CYP19A1—brain—multiple sclerosis	7.38e-05	0.0206	CbGeAlD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	7.29e-05	0.00102	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	7.26e-05	0.00102	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	7e-05	0.000984	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	6.87e-05	0.000966	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	6.87e-05	0.000966	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.83e-05	0.000959	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.83e-05	0.000959	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.72e-05	0.000944	CbGpPWpGaD
Terbinafine—PTGS1—spinal cord—multiple sclerosis	6.65e-05	0.0186	CbGeAlD
Terbinafine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.44e-05	0.000904	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GPC5—multiple sclerosis	6.29e-05	0.000883	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—APOE—multiple sclerosis	6.28e-05	0.000882	CbGpPWpGaD
Terbinafine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.13e-05	0.000861	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.1e-05	0.000857	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.84e-05	0.00082	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.84e-05	0.00082	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	5.8e-05	0.000815	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYP24A1—multiple sclerosis	5.79e-05	0.000813	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYP27B1—multiple sclerosis	5.79e-05	0.000813	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.68e-05	0.000797	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	5.67e-05	0.000797	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.66e-05	0.000795	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.65e-05	0.000794	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	5.65e-05	0.000794	CbGpPWpGaD
Terbinafine—PTGS1—nervous system—multiple sclerosis	5.6e-05	0.0156	CbGeAlD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.55e-05	0.00078	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—POMC—multiple sclerosis	5.4e-05	0.000758	CbGpPWpGaD
Terbinafine—PTGS1—central nervous system—multiple sclerosis	5.39e-05	0.0151	CbGeAlD
Terbinafine—CYP2C8—Metabolism—SRM—multiple sclerosis	5.3e-05	0.000745	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GPC5—multiple sclerosis	5.29e-05	0.000743	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.29e-05	0.000743	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.29e-05	0.000743	CbGpPWpGaD
Terbinafine—CYP2C8—brain—multiple sclerosis	5.28e-05	0.0147	CbGeAlD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.24e-05	0.000736	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—RRM1—multiple sclerosis	5.21e-05	0.000732	CbGpPWpGaD
Terbinafine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.97e-05	0.000698	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—ALB—multiple sclerosis	4.92e-05	0.000691	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.92e-05	0.000691	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.78e-05	0.000671	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—SRM—multiple sclerosis	4.73e-05	0.000665	CbGpPWpGaD
Terbinafine—CYP3A4—nervous system—multiple sclerosis	4.68e-05	0.0131	CbGeAlD
Terbinafine—CYP2D6—nervous system—multiple sclerosis	4.6e-05	0.0129	CbGeAlD
Terbinafine—CYP11A1—Metabolism—BCHE—multiple sclerosis	4.52e-05	0.000634	CbGpPWpGaD
Terbinafine—CYP3A4—central nervous system—multiple sclerosis	4.51e-05	0.0126	CbGeAlD
Terbinafine—CYP2D6—central nervous system—multiple sclerosis	4.43e-05	0.0124	CbGeAlD
Terbinafine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.39e-05	0.000616	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—RRM1—multiple sclerosis	4.38e-05	0.000616	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SRM—multiple sclerosis	4.35e-05	0.000612	CbGpPWpGaD
Terbinafine—CYP2D6—cerebellum—multiple sclerosis	4.33e-05	0.0121	CbGeAlD
Terbinafine—CYP2C9—Metabolism—SRM—multiple sclerosis	4.32e-05	0.000606	CbGpPWpGaD
Terbinafine—PTGS1—brain—multiple sclerosis	4.28e-05	0.012	CbGeAlD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.04e-05	0.000568	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.04e-05	0.000567	CbGpPWpGaD
Terbinafine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4e-05	0.000562	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.74e-05	0.000525	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.74e-05	0.000525	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SRM—multiple sclerosis	3.69e-05	0.000518	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.65e-05	0.000513	CbGpPWpGaD
Terbinafine—CYP2D6—brain—multiple sclerosis	3.52e-05	0.00983	CbGeAlD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.47e-05	0.000488	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.42e-05	0.00048	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.42e-05	0.00048	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.4e-05	0.000478	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.34e-05	0.000469	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.34e-05	0.000469	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.26e-05	0.000458	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.17e-05	0.000445	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.07e-05	0.000431	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.07e-05	0.000431	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.05e-05	0.000429	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.04e-05	0.000427	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.04e-05	0.000427	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—BCHE—multiple sclerosis	2.99e-05	0.00042	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.97e-05	0.000418	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.92e-05	0.000411	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.85e-05	0.0004	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.83e-05	0.000398	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.81e-05	0.000394	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.78e-05	0.000391	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—APOE—multiple sclerosis	2.72e-05	0.000382	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.66e-05	0.000374	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.64e-05	0.000371	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.6e-05	0.000365	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.6e-05	0.000365	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.54e-05	0.000357	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.53e-05	0.000355	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—BCHE—multiple sclerosis	2.52e-05	0.000354	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.38e-05	0.000334	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—POMC—multiple sclerosis	2.33e-05	0.000328	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.33e-05	0.000327	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.3e-05	0.000324	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.2e-05	0.000309	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—ALB—multiple sclerosis	2.13e-05	0.000299	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.01e-05	0.000282	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.01e-05	0.000282	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.97e-05	0.000277	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.96e-05	0.000276	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.89e-05	0.000265	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.83e-05	0.000258	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—APOE—multiple sclerosis	1.8e-05	0.000253	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.79e-05	0.000251	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.72e-05	0.000242	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.68e-05	0.000237	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.63e-05	0.000229	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—POMC—multiple sclerosis	1.55e-05	0.000217	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.54e-05	0.000216	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.54e-05	0.000216	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.53e-05	0.000215	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.52e-05	0.000214	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—APOE—multiple sclerosis	1.51e-05	0.000213	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.45e-05	0.000204	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ALB—multiple sclerosis	1.41e-05	0.000198	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.4e-05	0.000197	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000188	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.32e-05	0.000186	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.31e-05	0.000184	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—POMC—multiple sclerosis	1.3e-05	0.000183	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.2e-05	0.000168	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ALB—multiple sclerosis	1.19e-05	0.000167	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.000159	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—APOE—multiple sclerosis	9.79e-06	0.000137	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—APOE—multiple sclerosis	8.73e-06	0.000123	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.73e-06	0.000123	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—POMC—multiple sclerosis	8.41e-06	0.000118	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—APOE—multiple sclerosis	8.03e-06	0.000113	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APOE—multiple sclerosis	7.96e-06	0.000112	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ALB—multiple sclerosis	7.66e-06	0.000108	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—POMC—multiple sclerosis	7.5e-06	0.000105	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—POMC—multiple sclerosis	6.9e-06	9.69e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—POMC—multiple sclerosis	6.84e-06	9.61e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ALB—multiple sclerosis	6.84e-06	9.61e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOE—multiple sclerosis	6.81e-06	9.56e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALB—multiple sclerosis	6.29e-06	8.84e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALB—multiple sclerosis	6.24e-06	8.76e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—POMC—multiple sclerosis	5.85e-06	8.21e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALB—multiple sclerosis	5.33e-06	7.49e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOE—multiple sclerosis	5.25e-06	7.38e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—POMC—multiple sclerosis	4.51e-06	6.34e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALB—multiple sclerosis	4.11e-06	5.78e-05	CbGpPWpGaD
